BriaCell Therapeutics Corp.
BCTX · NASDAQ
7/31/2025 | 7/31/2024 | 7/31/2023 | 7/31/2022 | |
|---|---|---|---|---|
| Market Cap | $3,156 | $123,851 | $1,044,956 | $993,171 |
| - Cash | $14,428 | $1,197 | $28,381 | $52,635 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$11,272 | $122,654 | $1,016,574 | $940,536 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$148 | -$115 | -$21 | -$19 |
| % Margin | – | – | – | – |
| EBITDA | -$36,635 | -$6,624 | -$27,247 | -$34,106 |
| % Margin | – | – | – | – |
| Net Income | -$36,495 | -$6,547 | -$27,268 | -$34,127 |
| % Margin | – | – | – | – |
| EPS Diluted | -86.25 | -59.69 | -261.86 | -330.38 |
| % Growth | -44.5% | 77.2% | 20.7% | – |
| Operating Cash Flow | -$39,073 | -$32,968 | -$31,891 | -$15,874 |
| Capital Expenditures | $0 | -$624 | $0 | $0 |
| Free Cash Flow | -$39,073 | -$33,592 | -$31,891 | -$15,874 |